ClinicalTrials.Veeva

Menu

Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing

U

University of Child Health Sciences and Children's Hospital, Lahore

Status and phase

Completed
Phase 3

Conditions

Iron Deficiency Anemia
Iron Deficiency Anemia Treatment

Treatments

Drug: Ferrous sulphate

Study type

Interventional

Funder types

Other

Identifiers

NCT07267975
No/1032/CH-UCHS

Details and patient eligibility

About

Treating iron deficiency anemia in children with daily and alternate day oral iron therapy

Full description

Comparison of effectiveness of oral iron in daily and alternate group in children

Enrollment

60 patients

Sex

All

Ages

1 day to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

- Patients of both genders with ages in the range of 0 -60 months suffering from IDA as per operational definition.

Exclusion criteria

  • Who have already taken treatment for IDA during last 2-months as per history/clinical record.

Who have undergone recent blood transfusion during last 12-weeks as per history/clinical record.

Children with chronic kidney disease, chronic liver disease, cardiac failure or concomitant malignancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Continuous oral iron therapy
Active Comparator group
Description:
Oral iron daily dosing 6mg/kg/day
Treatment:
Drug: Ferrous sulphate
Drug: Ferrous sulphate
Intermittent oral iron
Experimental group
Description:
Oral iron therapy on alternate day with dose of 6mg /kg/day for 3 mons
Treatment:
Drug: Ferrous sulphate
Drug: Ferrous sulphate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems